Characterization of a Type II L-Asparaginase from the Halotolerant IBacillus subtilis/I CH11
L-asparaginases from bacterial sources have been used in antineoplastic treatments and the food industry. A type II L-asparaginase encoded by the N-truncated gene ansZP21 of halotolerant Bacillus subtilis CH11 isolated from Chilca salterns in Peru was expressed using a heterologous system in Escheri...
Gespeichert in:
Veröffentlicht in: | Life (Basel, Switzerland) Switzerland), 2023-10, Vol.13 (11) |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | L-asparaginases from bacterial sources have been used in antineoplastic treatments and the food industry. A type II L-asparaginase encoded by the N-truncated gene ansZP21 of halotolerant Bacillus subtilis CH11 isolated from Chilca salterns in Peru was expressed using a heterologous system in Escherichia coli BL21 (DE3)pLysS. The recombinant protein was purified using one-step nickel affinity chromatography and exhibited an activity of 234.38 U mg[sup.−1] and a maximum catalytic activity at pH 9.0 and 60 °C. The enzyme showed a homotetrameric form with an estimated molecular weight of 155 kDa through gel filtration chromatography. The enzyme half-life at 60 °C was 3 h 48 min, and L-asparaginase retained 50% of its initial activity for 24 h at 37 °C. The activity was considerably enhanced by KCl, CaCl[sub.2] , MgCl[sub.2] , mercaptoethanol, and DL-dithiothreitol (p-value < 0.01). Moreover, the V[sub.max] and K[sub.m] were 145.2 µmol mL[sup.−1] min[sup.−1] and 4.75 mM, respectively. These findings evidence a promising novel type II L-asparaginase for future industrial applications. |
---|---|
ISSN: | 2075-1729 2075-1729 |
DOI: | 10.3390/life13112145 |